Pooja Mahajan

Fellowship: Ph.D.: I am working on “Deciphering immuno-modulatory properties of alum and SPy_2191: a potent vaccine formulation against Group A Streptococcus”

Scientific interest: Group A Streptococcus (GAS) which causes a range of diseases, but vaccine development is hampered due to the large number of serotypes. Of note, not a single GAS vaccine has been approved or licensed for human use. Hence, development of a safe and effective GAS vaccine is the utmost need of the hour. We have used reverse vaccinology approach to solve this problem.

Publications

1. Pooja Mahajan, S Tomar, A Kumar, N Yadav, A Arya, VD Dwivedi (2020): A multi-target approach for discovery of antiviral compounds against dengue virus from green tea. Network Modelling Analysis in Health Informatics and Bioinformatics. 9, 1-10. 2. A Sharma, P Sanduja, A Anand, Pooja Mahajan, CA. Guzman, P Yadav,SK Sharma, A Awasthi, E Hanski, M Dua and AK Johri (2021): Advanced Strategies for Development of Vaccines against Important Human Pathogens. World Journal of Microbiology and Biotechnology. 37, 1-11. 3. SK Verma, Pooja Mahajan, NK Singh, A Gupta, R Aggarwal, R Rappuoli and AK Johri (2023): New age vaccine adjuvants, their development and future perspective. Frontiers in Immunology. 14, 1043109. https://doi.org/10.3389/fimmu.2023.1043109 4. Aggarwal, R., Mahajan P, Pandiya S, Bajaj A, Verma SK, Yadav P, Kharat AS, Khan AU, Dua M, Johri AK (2024). Antibiotic resistance: a global crisis, problems and solutions. Critical Reviews in Microbiology. 1-26. https://doi.org/10.1080/1040841X.2024.2313024